Published • loading... • Updated
Bladder Cancer: the Extent of Anktiva Enlargement
Summary by Hispanos Press
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Silver Spring (Maryland).- The U.S. Food and Drug Administration (FDA) expanded the authorized use of Anktiva, given with Bacillus Calmette-Guérin (BCG), for adults with high-grade papillary bladder cancer that has not invaded the muscle and did not respond to BCG treatment. The agency identifies Anktiva as the first [...]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
